Pliant Therapeutics, Inc.
PLRX· Nasdaq
Released Nov 9, 2023, after the close
10-Q filed Nov 9, 2023, 40 days after period end · 0001746473-23-000074
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $0.00 | $1.48M | $1.61M | $4.81M |
| Net Income | -$41.49M | -$30.62M | -$27.05M | -$16.53M |
| EPS Diluted |
Pliant Therapeutics, Inc. · CIK 1746473 · Engraved from SEC EDGAR
| -$0.70 |
| -$0.65 |
| -$0.75 |
| -$0.47 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.